Recent transactions
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Azoulay Salomon | Chief Medical Officer | S Sale | — | $65.77 | $24K | filing |
| May 11, 2026 | Azoulay Salomon | Chief Medical Officer | S SaleOE | — | $38.36 | $2.7M | filing |
MBX BIOSCIENCES INC Equity (MBX) insider trading activity (SEC Form 4). Over the trailing 90 days, MBX insiders filed 0 purchases totalling $0 and 2 sales totalling $2.7M — net SELLING of $2.7M. Most recent filing: Aug 5, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.